PROX1 expression, on the other hand, differed significantly by tumor size (P = 0.000), incidence of nodal (P = 0.007) and distant metastasis (P = 0.001), TNM clinical stage (P = 0.000), and incidence of tumor recurrence (P = 0.001, Table 2). Here, PROX1 is linked to neoplasm.